ASHEESH LAL, M.D.
Hematology & Oncology Physician · WEST COLUMBIA, SC
Individual Active NPI 1841223047
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,195 | 237,903 | $14,680,972 | $5,224,112 | $4,175,231 |
| 2023 | 1,262 | 260,147 | $15,754,412 | $5,497,016 | $4,380,275 |
| 2022 | 1,248 | 227,292 | $13,354,629 | $4,680,188 | $3,728,328 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1439 | Injection, ferric carboxymaltose, 1 mg | 36,750 | $1 | $1 |
| J9271 | Injection, pembrolizumab, 1 mg | 21,200 | $54 | $43 |
| J0897 | Injection, denosumab, 1 mg | 14,640 | $25 | $21 |
| Q5110 | Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 12,540 | $0 | $0 |
| J0185 | Injection, aprepitant, 1 mg | 12,480 | $2 | $1 |
| J9299 | Injection, nivolumab, 1 mg | 11,960 | $31 | $25 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 11,772 | $0 | $0 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 11,105 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 7,920 | $46 | $37 |
| J1453 | Injection, fosaprepitant, 1 mg | 4,800 | $0 | $0 |
| J9267 | Injection, paclitaxel, 1 mg | 3,833 | $0 | $0 |
| J9171 | Injection, docetaxel, 1 mg | 2,014 | $1 | $1 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 18615 | SC |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in South Carolina
- NPI 1699207886
- NPI 1952509671
- NPI 1164509873
- NPI 1700021847
- NPI 1801123864
- NPI 1932706264
- NPI 1548293749
- NPI 1073530432
See all Hematology & Oncology Physician providers in South Carolina →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.